Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease and a chronic systematic disease with unknown etiology influential more than one million individuals each year. The aim of this study is to substantiation the impact of IL4, C3 and C4 in patients with Systemic Lupus Erythematosus. During the period 2/January/2013 to 1/October/2013, fifty patients with Systemic Lupus Erythematosus that diagnosed by clinic specialists at female with ages ranged between (8-65) years, by using ANA indirect Immunofluorescence test, anti-dsDNA ELISA kit , C3,C4 Radial Immunodiffusion Plate , IL4 ELISA kit. There was an elevated levels of the parameters; ANA, anti-dsDNA and IL-4 that measured in SLE patients which reflect the severity of disease comparing with controls group, also there was importance of ANA, anti-dsDNA, C3, C4 and IL4 in the predictions of disease activity.
References
Yu SL, Kuan WP, Wong CK, Li EK, and Tam LS. (2012). Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus. Journal of Immunology Research, 2012.
Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, and James JA. (2007). Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis & Rheumatism, 56(7), 2344-2351.
Armstrong DJ, Crockard AD, Wisdom BG, Whitehead EM, and Bell AL. (2006). Accelerated apoptosis in SLE neutrophils cultured with anti-dsDNA antibody isolated from SLE patient serum: a pilot study. Rheumatology international, 27(2), 153-156.
Leffler J, Bengtsson AA, and Blom AM. (2014). The complement system in systemic lupus erythematosus: an update. Annals of the rheumatic diseases, annrheumdis- 2014.
Noreldin N, elshweek S, and Attia M, M. (2014). Biomarkers assay for identification and prediction of flare in patients with Systemic lupus Erythematosus. Journal of American Science, 10(10):105-111.
Mak A, and Tay SH. (2014). Environmental Factors, Toxicants and Systemic Lupus Erythematosus. International journal of molecular sciences, 15(9), 16043-16056.
Shankar S, and Behera V. (2014). Advances in management of systemic lupus erythematosus. Journal of Mahatma Gandhi Institute of Medical Sciences, 19(1), 28.
Tareen A, Naqi N, Afzal A, and Malik U. (2014). Diagnostic accuracy of antinuclear antibodies and anti- double stranded DNA antibodies in patients of systemic lupus erythematosus presenting with dermatological features. Journal of Pakistan Association of Dermatologists, 24(2), 127-131.
Der E, Trigunaite A, Khan A, and Jørgensen TN. (2014). Pro- and Anti-inflammatory Neutrophils in Lupus. J Clin Cell Immunol, 5:4.
Jain D, Aggarwal HK, Kaverappa V, Dhayia S, Jain P, and Yadav S. (2014). Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case. Reumatismo, 65(6), 302-306.
Su KY, and Pisetsky DS. (2009). The role of extracellular DNA in autoimmunity in SLE. Scandinavian journal of immunology, 70(3), 175-183.
Cava AL. (2009). Lupus and T cells. Lupus, 18(3), 196-
Choi P, and Reiser H. (1998). IL-4: role in disease and regulation of production. Clinical and experimental immunology, 113, 317-319.
Shiroiwa W, Tsukamoto K, Ohtsuji M, Lin Q, Ida A,
Kodera S, et al. (2007). IL-4Rα polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. International immunology, 19(2), 175-183.
Mahmoudi M, Tahghighi F, Ziaee V, Harsini S, Rezaei A, Soltani S Sadr M, Moradinejad MH, Aghighi Y. and Rezaei N. (2014). Interleukin‐4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. International journal of immunogenetics, 41(6), 512- 517.
O'Garra A, Steinman L, and Gijbels K. (1997). CD4+ T-cell subsets in autoimmunity. Current opinion in immunology, 9(6), 872-883.
Einav S, Pozdnyakova OO, Ma M, and Carroll MC. (2002). Complement C4 is protective for lupus disease independent of C3. The Journal of Immunology, 168(3), 1036-1041.
Kenyon KD, Cole C, Crawford F, Kappler JW, Thurman JM, and Bratton DL, et al. (2011). IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity. The Journal of Immunology, 187(5), 2101-2111.
Grossmayer GE, Munoz LE, Weber CK, Franz S, Voll RE, and Kern PM, et al. (2008). IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera. Annals of the rheumatic diseases, 67(11), 1626-1632.
Manderson AP, Botto M, and Walport MJ. (2004). The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol., 22, 431-456.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array